These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22462650)

  • 1. Role of comorbidities in outcome prediction after status epilepticus.
    Alvarez V; Januel JM; Burnand B; Rossetti AO
    Epilepsia; 2012 May; 53(5):e89-92. PubMed ID: 22462650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of status epilepticus: prognostic role and outcome predictors.
    Tsetsou S; Novy J; Rossetti AO
    Epilepsia; 2015 Mar; 56(3):473-8. PubMed ID: 25580861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status epilepticus: an independent outcome predictor after cerebral anoxia.
    Rossetti AO; Logroscino G; Liaudet L; Ruffieux C; Ribordy V; Schaller MD; Despland PA; Oddo M
    Neurology; 2007 Jul; 69(3):255-60. PubMed ID: 17636063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory status epilepticus: Impact of baseline comorbidity and usefulness of STESS and EMSE scoring systems in predicting mortality and functional outcome.
    Ciurans J; Grau-López L; Jiménez M; Fumanal A; Misis M; Becerra JL
    Seizure; 2018 Mar; 56():98-103. PubMed ID: 29462742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours.
    Drislane FW; Blum AS; Lopez MR; Gautam S; Schomer DL
    Epilepsia; 2009 Jun; 50(6):1566-71. PubMed ID: 19175387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing in-hospital and out-of-hospital status epilepticus: clinical implications from a 10-year cohort study.
    Sutter R; Semmlack S; Spiegel R; Tisljar K; Rüegg S; Marsch S
    Eur J Neurol; 2017 Sep; 24(9):1156-1165. PubMed ID: 28727267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores.
    Kang BS; Kim DW; Kim KK; Moon HJ; Kim YS; Kim HK; Lee SY; Koo YS; Shin JW; Moon J; Sunwoo JS; Byun JI; Cho YW; Jung KY; Chu K; Lee SK
    Crit Care; 2016 Jan; 20():25. PubMed ID: 26812954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status epilepticus severity score (STESS): A useful tool to predict outcome of status epilepticus.
    Goyal MK; Chakravarthi S; Modi M; Bhalla A; Lal V
    Clin Neurol Neurosurg; 2015 Dec; 139():96-9. PubMed ID: 26409183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores.
    Giovannini G; Monti G; Tondelli M; Marudi A; Valzania F; Leitinger M; Trinka E; Meletti S
    Seizure; 2017 Mar; 46():31-37. PubMed ID: 28226274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of status epilepticus and the predictive value of the EMSE and STESS scores: A prospective study.
    Sairanen JJ; Kantanen AM; Hyppölä HT; Kälviäinen RK
    Seizure; 2020 Feb; 75():115-120. PubMed ID: 31945716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of refractoriness in a Turkish status epilepticus data bank.
    Agan K; Afsar N; Midi I; Us O; Aktan S; Aykut-Bingol C
    Epilepsy Behav; 2009 Apr; 14(4):651-4. PubMed ID: 19435569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in refractory status epilepticus.
    Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
    JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivors and nonsurvivors of very prolonged status epilepticus.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    Epilepsy Behav; 2011 Oct; 22(2):342-5. PubMed ID: 21840765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.
    Alvarez V; Lee JW; Westover MB; Drislane FW; Novy J; Faouzi M; Marchi NA; Dworetzky BA; Rossetti AO
    Neurology; 2016 Oct; 87(16):1650-1659. PubMed ID: 27664985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predictive of outcome in patients with de novo status epilepticus.
    Tsai MH; Chuang YC; Chang HW; Chang WN; Lai SL; Huang CR; Tsai NW; Wang HC; Lin YJ; Lu CH
    QJM; 2009 Jan; 102(1):57-62. PubMed ID: 19015144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis.
    Jaques L; Rossetti AO
    Epilepsy Behav; 2012 May; 24(1):70-3. PubMed ID: 22481040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients.
    Amare A; Zenebe G; Hammack J; Davey G
    Epilepsia; 2008 Apr; 49(4):600-7. PubMed ID: 18325017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.